Helle Holtveg

Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial

Jayant S. Vaidya, Frederik Wenz, Max Bulsara et al. · The Lancet · 2013 · 822 citations · Full text

Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial

Jayant S. Vaidya, David Joseph, Jeffrey Tobias et al. · The Lancet · 2010 · 756 citations · Full text

Surgical Oncology, Breast Oncology, Radiation Therapy +7

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale et al. · The Lancet Oncology · 2018 · 533 citations

Surgical Oncology, Breast Oncology, Medicine +7

Effect of breast‐conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma

Niels Kroman, Helle Holtveg, Jan Wohlfahrt et al. · Cancer · 2004 · 145 citations · Full text

Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: A study from the Danish Breast Cancer Cooperative Group

Anders Husted Madsen, Karen Haugaard, Jan Soerensen et al. · The Breast · 2007 · 111 citations · Full text